...
首页> 外文期刊>Journal of mammary gland biology and neoplasia >Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing
【24h】

Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing

机译:通过整合基因组分析和CRISPR / CAS9基因组编辑来解剖组织特异性超增强剂

获取原文
获取原文并翻译 | 示例
           

摘要

Recent advances in genome-wide sequencing technologies have provided researchers with unprecedented opportunities to discover the genomic structures of gene regulatory units in living organisms. In particular, the integration of ChIP-seq, RNA-seq, and DNase-seq techniques has facilitated the mapping of a new class of regulatory elements. These elements, called super-enhancers, can regulate cell-type-specific gene sets and even fine-tune gene expression regulation in response to external stimuli, and have become a hot topic in genome biology. However, there is scant genetic evidence demonstrating their unique biological relevance and the mechanisms underlying these biological functions. In this review, we describe a robust genome-wide strategy for mapping cell-type-specific enhancers or super-enhancers in the mammary genome. In this strategy, genome-wide screening of active enhancer clusters that are co-occupied by mammary-enriched transcription factors, co-factors, and active enhancer marks is used to identify bona fide mammary tissue-specific super-enhancers. The in vivo function of these super-enhancers and their associated regulatory elements may then be investigated in various ways using the advanced CRISPR/Cas9 genome-editing technology. Based on our experience targeting various mammary genomic sites using CRISPR/Cas9 in mice, we comprehensively discuss the molecular consequences of the different targeting methods, such as the number of gRNAs and the dependence on their simultaneous or sequential injections. We also mention the considerations that are essential for obtaining accurate results and shed light on recent progress that has been made in developing modified CRISPR/Cas9 genome-editing techniques. In the future, the coupling of advanced genome-wide sequencing and genome-editing technologies could provide new insights into the complex genetic regulatory networks involved in mammary-gland development.
机译:基因组测序技术的最新进展为研究人员提供了前所未有的机会,以发现生物体中基因调控单位的基因组结构。特别地,芯片-SEQ,RNA-SEQ和DNase-SEQ技术的整合促进了一类新的调节元件的映射。这些元素称为超强增强剂,可以调节细胞类型特异性基因集,甚至响应外部刺激的微调基因表达调节,并且已成为基因组生物学中的热门话题。然而,有遗传的遗传证据表明了它们独特的生物相关性和这些生物学功能的机制。在本次综述中,我们描述了用于在乳腺基因组中映射细胞类型特异性增强剂或超增强剂的稳健基因组策略。在该策略中,通过富集的转录因子,共同因子和活性增强剂标记共同占用的活性增强剂簇的基因组筛选,用于鉴定Bona FIDE乳腺组织特异性超增强剂。然后可以使用先进的CRISPR / CAS9基因组编辑技术以各种方式研究这些超增强剂的体内功能及其相关的调节元件。基于我们在小鼠中使用CRISPR / CAS9靶向各种乳腺基因组位点的经验,我们全面地讨论了不同靶向方法的分子后果,例如GRNA的数量和对同时或顺序注射的依赖性。我们还提到了在开发修改的CRAP / CAS9基因组编辑技术方面取得最近进展的准确成果和揭示光线的考虑因素。将来,先进的基因组测序和基因组编辑技术的偶联可以为乳腺开发中涉及的复杂遗传调节网络提供新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号